Institute of Clinical Molecular Biology

Director(s):

  • Prof. Dr. Stefan Schreiber
  • Prof. Dr. Philip Rosenstiel
  • Prof. Dr. Andre Franke


The Institute of Clinical Molecular Biology (IKMB) deals with the clinical implementation of molecular biological research approaches in the fields of chronic inflammatory diseases and gerontology. The Institute's scientific strategy in relation to this involves the evaluation of genetic variants and epigenetic mutations at the DNA level, the systematic evaluation of transcriptional regulation, the analysis of changes at protein level and understanding the function of relevant genetic signals. An important focus here is the characterisation of physiological and pathological interactions between epithelial barrier organs and colonising microbial flora (microbiom). The aim is to use research results in new, innovative treatments.

The Institute is part of both Clusters of Excellence 'Inflammation at Interfaces' and 'The Future Ocean' and the BMBF e:Med Netzwerk für System Medizin (Network for Systems Medicine) and in other research associations of the BMBF (IHEC, ICGC),  DFG (GRK 1743, CRC 877) and EU. It also has a close relationship with the Biobank Popgen and the Comprehensive Center for Inflammation Medicine ensuring an approach to research that is close to the patient.
Since the start of 2012 the IKMB is responsible for health care activities at the UKSH in the field of molecular genetic diagnostics and is affiliated with the Diagnostikzentrum (diagnostics centre) and the Institute of Clinical Chemistry.